Maier, A G <br/><br/>
Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial.  [electronic resource] 

 -  Journal of magnetic resonance imaging : JMRI  Nov 2000 
 - 651-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1053-1807 
<br/><br/><label>Standard No.: </label>10.1002/1522-2586(200011)12:5<651::aid-jmri1>3.0.co;2-r  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Administration, Rectal<br/>Adult<br/>Aged<br/>Biopsy, Needle<br/>Chi-Square Distribution<br/>Contrast Media<br/>Dose-Response Relationship, Drug<br/>Female<br/>Ferric Compounds<br/>Gadolinium DTPA<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Injections, Intravenous<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Middle Aged<br/>Neoplasm Staging--methods<br/>Preoperative Care<br/>Probability<br/>ROC Curve<br/>Rectal Neoplasms--diagnosis<br/>Sensitivity and Specificity